The company announced poster presentations for the ASCO virtual meeting on AMG 510, its KRAS G12c inhibitor, in patients with colorectal cancer and a broad range of cancers. But an analyst called the drug “unimpressive” outside of non-small cell lung cancer.

LEAVE A REPLY

Please enter your comment!
Please enter your name here